Alnylam Pharmaceuticals shares owned by Peregrine Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Peregrine Capital Management
from 13F filings
Historical chart of Peregrine Capital Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Peregrine Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Peregrine Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $171k | 1.1k | 149.45 |
| 2023-12-31 | $220k | 1.1k | 191.41 |
| 2023-09-30 | $203k | 1.1k | 177.10 |
| 2023-06-30 | $218k | 1.1k | 189.94 |
| 2023-03-31 | $230k | 1.1k | 200.32 |
| 2022-12-31 | $273k | 1.1k | 238.01 |
| 2022-09-30 | $230k | 1.1k | 200.52 |
| 2022-06-30 | $201k | 1.4k | 145.65 |
| 2022-03-31 | $225k | 1.4k | 163.04 |
| 2021-12-31 | $234k | 1.4k | 169.57 |
| 2021-09-30 | $261k | 1.4k | 189.13 |
| 2021-06-30 | $234k | 1.4k | 169.57 |
| 2021-03-31 | $195k | 1.4k | 141.30 |
| 2020-12-31 | $179k | 1.4k | 129.71 |
| 2020-09-30 | $201k | 1.4k | 145.65 |
| 2020-06-30 | $14M | 95k | 148.11 |
| 2020-03-31 | $12M | 109k | 108.85 |
| 2019-12-31 | $18M | 153k | 115.17 |
| 2019-09-30 | $15M | 191k | 80.42 |
| 2019-06-30 | $17M | 231k | 72.56 |
| 2019-03-31 | $18M | 193k | 93.45 |
| 2018-12-31 | $14M | 197k | 72.91 |
| 2018-09-30 | $17M | 198k | 87.52 |
| 2018-06-30 | $18M | 179k | 98.49 |
| 2018-03-31 | $17M | 142k | 119.10 |
| 2017-12-31 | $19M | 148k | 127.05 |
| 2017-09-30 | $19M | 165k | 117.49 |
| 2017-06-30 | $16M | 199k | 79.76 |
| 2017-03-31 | $12M | 222k | 52.83 |
| 2016-12-31 | $7.7M | 206k | 37.44 |
| 2016-09-30 | $13M | 184k | 67.78 |
More positions owned by Peregrine Capital Management
View all positions for Peregrine Capital Management